$KPRX Broadening formationNot financial advice.
NASDAQ:KPRX
Broadening formation also huge gap or purple box. time will tell.
Like and subscribe for more ideas.
Thanks.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.68 USD
−12.51 M USD
0.00 USD
2.80 M
About Kiora Pharmaceuticals, Inc.
Sector
CEO
Brian Matthew Strem
Headquarters
Encinitas
Website
Founded
1998
FIGI
BBG0083Y1PH9
Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.
KPRX possible runKRPX with news, this stock is declining since ever.
There is a great possibility to run to $20
$KPRX Target PT 2 and higherKiora Pharmaceuticals to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference
Salt Lake City, Utah--(Newsfile Corp. - January 5, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) will participate in the H.C. Wainwright Bioconnect Virtual Conference January 10-13, 2022
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of KPRX is 3.35 USD — it has increased by 5.88% in the past 24 hours. Watch Kiora Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Kiora Pharmaceuticals, Inc. stocks are traded under the ticker KPRX.
KPRX stock has fallen by −5.52% compared to the previous week, the month change is a 0.29% rise, over the last year Kiora Pharmaceuticals, Inc. has showed a −33.05% decrease.
We've gathered analysts' opinions on Kiora Pharmaceuticals, Inc. future price: according to them, KPRX price has a max estimate of 54.00 USD and a min estimate of 10.00 USD. Watch KPRX chart and read a more detailed Kiora Pharmaceuticals, Inc. stock forecast: see what analysts think of Kiora Pharmaceuticals, Inc. and suggest that you do with its stocks.
KPRX reached its all-time high on Jul 22, 2015 with the price of 189,000.00 USD, and its all-time low was 3.00 USD and was reached on Aug 13, 2024. View more price dynamics on KPRX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
KPRX stock is 2.09% volatile and has beta coefficient of 1.45. Track Kiora Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Kiora Pharmaceuticals, Inc. there?
Today Kiora Pharmaceuticals, Inc. has the market capitalization of 10.26 M, it has increased by 0.68% over the last week.
Yes, you can track Kiora Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Kiora Pharmaceuticals, Inc. is going to release the next earnings report on Feb 28, 2025. Keep track of upcoming events with our Earnings Calendar.
KPRX earnings for the last quarter are −0.81 USD per share, whereas the estimation was −0.76 USD resulting in a −6.11% surprise. The estimated earnings for the next quarter are −0.60 USD per share. See more details about Kiora Pharmaceuticals, Inc. earnings.
Kiora Pharmaceuticals, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 10.50 K USD. In the next quarter, revenue is expected to reach 507.67 K USD.
KPRX net income for the last quarter is −3.41 M USD, while the quarter before that showed −2.22 M USD of net income which accounts for −53.64% change. Track more Kiora Pharmaceuticals, Inc. financial stats to get the full picture.
No, KPRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 12.00 employees. See our rating of the largest employees — is Kiora Pharmaceuticals, Inc. on this list?
Like other stocks, KPRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kiora Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kiora Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kiora Pharmaceuticals, Inc. stock shows the sell signal. See more of Kiora Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.